TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations
ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its “SMID Cap Growth Strategy”. A copy can be downloaded here.
Posts Tagged ‘NASDAQ:TGTX’
10 Best Performing American Stocks in June 2026
June’s biggest American stock winners came during a market where investors were highly rewarding companies tied to earnings growth, AI infrastructure, cyclicals, and sector-...
Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?
Is TGTX a good stock to buy? We came across a bullish thesis on TG Therapeutics, Inc. on TradersPro’s Substack.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2026 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2026 Earnings Call Transcript May 6, 2026TG Therapeutics, Inc. misses on earnings expectations.
BRIUMVI Momentum Leads to Strong Execution for TG Therapeutics (TGTX)
On February 26, TG Therapeutics Inc. (NASDAQ:TGTX) reported Q4 revenue of $192.6 million compared with consensus estimates of $193.3 million.
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds
On February 5, J.P. Morgan shared its views on trends that are expected to define healthcare in 2026.
Bank of America Securities Bearish on TG Therapeutics (TGTX) Post Earnings
TG Therapeutics, Inc. (NASDAQ:TGTX) is one of the 13 Most Profitable Growth Stocks to Buy Right Now.
13 Most Profitable Growth Stocks to Buy Right Now
Equity markets remain volatile amid geopolitical uncertainties.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics Fourth Quarter and Year-End 2025 Earnings Call. [Operator Instructions] Please note, this conference is being recorded.
TG Therapeutics (TGTX) Reports Financial Results for Q4 and Full Year 2025
TG Therapeutics, Inc. (NASDAQ:TGTX) is one of the best cheap biotech stocks to buy now. TG Therapeutics, Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Goldman Sachs Raises TG Therapeutics, Inc. (TGTX) Target to $39 on 2026 Guidance
On January 15, Goldman Sachs raised its price target on TG Therapeutics, Inc. (NASDAQ:TGTX) to $39 from $37 while maintaining a Neutral rating.
10 Best Long Term Healthcare Stocks to Buy
Investing in healthcare stocks offers a combination of defensive stability and long-term growth potential, supported by consistent demand for medical services, pharmaceuticals...
TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan
On February 2, JPMorgan analyst Brian Cheng reduced the price target on TG Therapeutics (NASDAQ:TGTX) to $46 from $49 while maintaining the Overweight rating on the shares.
13 Best Revenue Growth Stocks to Buy Right Now
Speaking to CNBC on January 13, Ari Wald, Head of Technical Analysis at Oppenheimer, said U.S.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript November 3, 2025TG Therapeutics, Inc. beats earnings expectations.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2025 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2025 Earnings Call Transcript August 4, 2025TG Therapeutics, Inc. misses on earnings expectations.
TG Therapeutics (TGTX) Slashes 18% on Lower 2025 Sales Guidance
In a statement, TG Therapeutics, Inc. (NASDAQ:TGTX) raised its revenue outlook for Briumvi to a range of $570 million to $575 million from the $560 million previously, but was...
14 Stocks Jim Cramer Recently Looked At
“Who is powering this market higher?... I think it's the young people, people who are part of the great wealth transfer...
10 Best Cancer Stocks to Invest in for Long-Term Gains
After cardiovascular disease, cancer is the second most common cause of mortality worldwide.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to TG Therapeutics First Quarter Conference Call and Webcast. At this time, all participants are in a listen-only mode.
10 Best Short Squeeze Stocks to Buy According to Analysts
Stock market trading has an ever-changing environment. Short squeeze is among the few phenomena capable of capturing and holding the attention of such markets.
10 Best Performing Growth Stocks in 2025
Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2024 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2024 Earnings Call Transcript March 3, 2025TG Therapeutics, Inc. beats earnings expectations.
12 Hot Stocks to Buy According to Analysts
While the stock market in the United States remained closed on January 20 for Martin Luther King, Jr.
Why TGTX Stock Is Rallying Today
The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million.
Should You Invest in TG Therapeutics (TGTX)?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” fourth quarter 2024 investor letter.
10 Stocks That Will Make You Rich In 2025
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript November 4, 2024TG Therapeutics, Inc. misses on earnings expectations.
10 Stocks Set to Explode in 2025
As the Magnificent Seven continues to release earnings for the fiscal third quarter of 2024, investors are keen to see if the group can maintain their market leading position ...
14 Worst 52-Week High Stocks to Buy According to Short Sellers
The start of the US Federal Reserve cutting cycle ushers a new era in the investment world after one of the longest bull runs.
TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
We came across a bullish thesis on TG Therapeutics Inc (TGTX) on ValueInvestorsClub by Bohr. In this article we will summarize the bulls' thesis on TGTX.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2024 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2024 Earnings Call Transcript August 6, 2024TG Therapeutics, Inc. beats earnings expectations.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics Conference Call and Webcast. At this time all participants are in a listen-only mode.
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript
TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. TG Therapeutics, Inc.
5 Best Growth Stocks Under $25
In this article, we discuss 5 best growth stocks under $25.
11 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics Third Quarter Earnings Update Call. [Operator Instructions] As a reminder, this conference is being recorded.
13 Stocks to Buy with Exponential Growth
Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish stance for the rest of the year amid rising...
15 Best U.S. Stocks to Buy Now Under $10
In this article, we will discuss the 15 best U.S. stocks to buy now under $10. If you want to explore similar stocks, you can also take a look at 5 Best U.S.
10 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 10 healthcare stocks to buy.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics Second Quarter 2023 Financial Results and Business Update Call.
5 Oversold Small Cap Stocks To Buy
In this piece, we will take a look at the five oversold small cap stocks to buy.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics Fourth Quarter and Year-End 2022 Earnings Call. At this time, all participants are in a listen-only mode.
5 Best Biotech Stocks to Buy Under $10
Ovid Therapeutics Inc. (NASDAQ:OVID) is an emerging biotech company that designs therapies for epilepsies, seizure-related disorders, and neurological disorders.
Hedge Fund and Insider Trading News: Ray Dalio, VGI Partners, Alden Global Capital, Radcliffe Group, Spouting Rock Asset Management, Dimensional Fund Advisors, Thornburg Income Builder Opportunities Trust (TBLD), TG Therapeutics Inc (TGTX), and More
Australian hedge fund VGI Partners is considering a merger of sale of its business with several rival firms including Regal Funds Management, according to a report in the Sydney...
5 Healthcare Stocks to Buy According to Lee Ainslie’s Maverick Capital
In this piece, we will take a look at the 5 healthcare stocks to buy according to Lee Ainslie's Maverick Capital. If you want to learn more about Mr.
Do Hedge Funds Love TG Therapeutics Inc (TGTX)?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Hedge Fund Resource Center
